在COVID-19期间的儿童面感染:我们学到了什么?
Shiran Sudri1, Maisa Pharayra2, Yasmin Ghantous3
1Department of Oral and Maxillofacial Surgery, Tzafon Medical Center, Affiliated with Azrieli Faculty of Medicine, Bar Ilan University, Israel.
概括
在COVID-19期间,儿科大面牙感染减少,但住院率上升. 许多病例可以在社区环境中得到治疗,减少急诊室的访问.
科学领域:
- 口腔和牙面部外科手术
- 儿科牙科 儿科牙科
- 传染性疾病 传染性疾病
背景情况:
- COVID-19大流行影响了包括牙科在内的全球医疗保健.
- 儿科口腔感染带来了独特的诊断和治疗挑战.
研究的目的:
- 为了比较COVID-19大流行期间与COVID-19前时代期间的儿科大面牙感染的发病率,特征和治疗.
主要方法:
- 儿科患者 (0-18岁) 的回顾性队列研究,诊断出大面牙感染.
- 从2020年3月至2021年2月 (COVID-19) 的数据与2018年3月至2020年2月 (COVID-19之前) 的数据进行比较.
- 统计分析包括费舍尔的精确测试,皮尔森的χ2测试,威尔科克森的等级和和测试,以及后勤回归.
主要成果:
- 在COVID-19期间,因牙感染而访问急诊室的数量显著减少 (RR=0.65,P=.0001).
- 住院率从COVID-19前的72%增加到COVID-19期间的86.8% (P=.001).
- 在COVID-19期间,住院时间显著缩短 (P<.001).
结论:
- 在COVID-19大流行期间,小儿大面牙感染显著减少,在急诊室呈现.
- 研究结果表明,在社区卫生保健机构中,有可能对某些感染进行管理.
- 这可能会减轻应急部门对这些特定条件的负担.
相关概念视频
Tonsillitis II: Management
110
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
110
Acute Pharyngitis
597
Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
597
Tonsillitis I: Introduction
237
Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
Etiology
Three primary contributing factors have been identified.
237
Pneumonia IV: Management
323
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
323
Factors Affecting the Risk of Infection
11.8K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
11.8K
Pneumonia III: Complications and Assessment
203
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
203


